0001209191-11-031210.txt : 20110526
0001209191-11-031210.hdr.sgml : 20110526
20110526155756
ACCESSION NUMBER: 0001209191-11-031210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110525
FILED AS OF DATE: 20110526
DATE AS OF CHANGE: 20110526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Lisa
CENTRAL INDEX KEY: 0001349077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11874068
MAIL ADDRESS:
STREET 1: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-05-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001349077
Kelly Lisa
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2011-05-25
4
S
0
1960
55.49
D
40212
D
Common Stock
2011-05-25
4
S
0
2200
56.22
D
38082
D
Common Stock
1520
I
401(k)
Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $55.49 (range $55.05 to $55.92).
Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $56.22 (range $56.04 to $56.57).
Kenneth S. Boger, Attorney-In-Fact
2011-05-26